(Reuters) - Johnson & Johnson said on Thursday it has asked U.S. health regulators to authorize its single-dose COVID-19 vaccine for emergency use, and it will apply to European authorities in coming ...

The investigational monoclonal antibody, VYD2311, (Invivyd) met all primary and key secondary endpoints in the phase 3 LIBERTY study. It showed safety and tolerability superior to an mRNA-based ...

The European Medicines Agency (EMA) announced Tuesday that Janssen, a division of Johnson & Johnson, has submitted an application for conditional marketing authorization for its one-dose vaccine ...

The Air Force says it’s aiming to eliminate a roughly 30-day bottleneck in the application process for reinstating former airmen discharged for refusing the COVID-19 vaccine.

The Defense Logistics Agency has developed a new dashboard application to provide real-time metrics as it packs and distributes millions of free COVID-19 at-home tests to American households as part ...